Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1. Unaudited financial results of the Company for the Quarter ended June 30, 2026 (both Standalone & Consolidated) 2. recommendation of Final Dividend, if any, for the FY 2025-26 and fixation of record date for this purpose.